Cargando…
COVID-19 vaccines: neutralizing antibodies and the alum advantage
Achieving high levels of neutralizing antibodies to the spike protein of SARS-CoV-2 in a safe manner is likely to be crucial for an effective vaccine. Here, we propose that aluminium-based adjuvants might hold the key to this.
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271131/ https://www.ncbi.nlm.nih.gov/pubmed/32499636 http://dx.doi.org/10.1038/s41577-020-0358-6 |